Methanesulfonic Acid Cinepazide Injection for Treatment of Acute Cerebral Infarction

Not yet recruiting

Phase 2 Results N/A

Summary of Purpose

Using placebo as control, The purpose of this study is to evaluate the efficacy and safety of methanesulfonic acid cinepazide injection to relieve disabled degree of acute cerebral infarction patients, and explore the best safe and effective dose as well as dose method.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 7 May 2013.

1 Oct 2013 7 May 2013 1 Aug 2014 1 Aug 2014 1 May 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Gang Zhao, Doctor